RIA
ARKG icon

Realta Investment Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Realta Investment Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-461
Closed -$10.8K – 378
2024
Q2 		$10.8K Sell
461
-53
-10% -$1.34K ﹤0.01% 670
2024
Q1 		$14.8K Buy
+514
New +$15.5K ﹤0.01% 668
2023
Q4 		– Sell
-604
Closed -$20.6K – 456
2023
Q3 		$20.6K Sell
604
-6
-1% -$196 ﹤0.01% 610
2023
Q2 		$20.8K Buy
+610
New +$19.2K ﹤0.01% 655
2023
Q1 		– Sell
-990
Closed -$27.9K – 440
2022
Q4 		$27.9K Buy
990
+106
+12% +$3.36K 0.01% 611
2022
Q3 		$29K Buy
+884
New +$32.5K 0.01% 587
2022
Q2 		– Sell
-9,504
Closed -$437K – 394
2022
Q1 		$437K Sell
9,504
-111
-1% -$5.29K 0.09% 236
2021
Q4 		$589K Buy
9,615
+5,529
+135% +$382K 0.13% 186
2021
Q3 		$305K Sell
4,086
-691
-14% -$58K 0.07% 293
2021
Q2 		$442K Sell
4,777
-882
-16% -$75K 0.1% 228
2021
Q1 		$502K Buy
5,659
+1,786
+46% +$177K 0.13% 197
2020
Q4 		$361K Buy
+3,873
New +$309K 0.1% 213

Other funds holding ARKG

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Realta Investment Advisors's ARKG Position: Q3 2024 in Review

Realta Investment Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2024, closing a stake of 461 shares — an estimated $10.8K sold.

Realta Investment Advisors first reported a position in ARKG in Q4 2020 and held it in 12 quarters. The position peaked at $589K in Q4 2021. 238 funds tracked by Wall St. Rank hold ARKG as of Q3 2024.

  • Realta Investment Advisors reported no remaining ARK Genomic Revolution ETF position as of Q3 2024 after selling out during the quarter.
  • Realta Investment Advisors sold 461 ARK Genomic Revolution ETF shares in Q3 2024, an estimated $10.8K.
  • Realta Investment Advisors first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 12 quarters.
  • Realta Investment Advisors's ARK Genomic Revolution ETF position peaked at $589K in Q4 2021.
  • 238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2024.

Based on Realta Investment Advisors's 13F filing for Q3 2024, filed 29 Oct 2024.